- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 25 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.3: 3 residues within 4Å:- Chain A: N.43, D.53, R.416
Ligand excluded by PLIPSO4.4: 2 residues within 4Å:- Chain A: K.73, R.499
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: W.89, Y.90, T.91
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: V.150, T.155, R.163
Ligand excluded by PLIPSO4.7: 4 residues within 4Å:- Chain A: R.94, Y.107, N.206, W.318
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain B: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.14: 3 residues within 4Å:- Chain B: N.386, T.389, D.393
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain B: N.43, D.53, R.416
Ligand excluded by PLIPSO4.16: 3 residues within 4Å:- Chain B: W.89, Y.90, T.91
Ligand excluded by PLIPSO4.17: 1 residues within 4Å:- Chain B: R.499
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain B: V.150, T.155, R.163
Ligand excluded by PLIPSO4.19: 4 residues within 4Å:- Chain B: R.94, Y.107, N.206, W.318
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain C: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain C: V.150, T.155, R.163
Ligand excluded by PLIPSO4.30: 2 residues within 4Å:- Chain C: K.73, R.499
Ligand excluded by PLIPSO4.31: 3 residues within 4Å:- Chain C: N.43, D.53, R.416
Ligand excluded by PLIPSO4.32: 2 residues within 4Å:- Chain C: P.117, K.118
Ligand excluded by PLIPSO4.33: 4 residues within 4Å:- Chain C: R.94, Y.107, N.206, W.318
Ligand excluded by PLIPSO4.39: 4 residues within 4Å:- Chain D: P.310, E.311, R.312, K.405
Ligand excluded by PLIPSO4.40: 2 residues within 4Å:- Chain D: K.202, T.203
Ligand excluded by PLIPSO4.41: 2 residues within 4Å:- Chain D: P.117, K.118
Ligand excluded by PLIPSO4.42: 3 residues within 4Å:- Chain D: V.150, T.155, R.163
Ligand excluded by PLIPSO4.43: 3 residues within 4Å:- Chain D: N.43, D.53, R.416
Ligand excluded by PLIPSO4.44: 4 residues within 4Å:- Chain D: R.94, Y.107, N.206, W.318
Ligand excluded by PLIP- 17 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.8: 3 residues within 4Å:- Chain A: W.446, N.474
- Chain C: E.497
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain A: G.65, V.67, W.318, R.330
- Ligands: FDA.1
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: I.68, F.69, S.70, T.212, F.213, R.214
Ligand excluded by PLIPEDO.11: 7 residues within 4Å:- Chain A: W.181, L.182, G.183, E.457, P.487, D.488, N.491
Ligand excluded by PLIPEDO.20: 2 residues within 4Å:- Ligands: EDO.23, EDO.26
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain B: W.446, N.474
- Chain D: E.497
Ligand excluded by PLIPEDO.22: 5 residues within 4Å:- Chain B: G.65, V.67, W.318, R.330
- Ligands: FDA.12
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain B: Q.101, E.119, E.120
- Ligands: EDO.20, EDO.26
Ligand excluded by PLIPEDO.24: 6 residues within 4Å:- Chain B: W.181, L.182, G.183, P.487, D.488, N.491
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain B: E.430, R.455, L.484, N.485, P.487
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain B: P.117, E.119
- Ligands: EDO.20, EDO.23
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain A: E.497
- Chain C: W.446, N.474
Ligand excluded by PLIPEDO.35: 5 residues within 4Å:- Chain C: V.67, I.68, F.69, R.94, N.460
Ligand excluded by PLIPEDO.36: 5 residues within 4Å:- Chain C: E.430, R.455, L.484, N.485, P.487
Ligand excluded by PLIPEDO.37: 5 residues within 4Å:- Chain C: E.120, K.123, G.156, D.159, L.160
Ligand excluded by PLIPEDO.45: 3 residues within 4Å:- Chain B: E.497
- Chain D: W.446, N.474
Ligand excluded by PLIPEDO.46: 6 residues within 4Å:- Chain D: W.181, L.182, G.183, P.487, D.488, N.491
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Da Fonseca, I. et al., Contributions of Unique Active Site Residues of Eukaryotic UDP-Galactopyranose Mutases to Substrate Recognition and Active Site Dynamics. Biochemistry (2014)
- Release Date
- 2014-12-03
- Peptides
- UDP-galactopyranose mutase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE(Non-covalent)
- 25 x SO4: SULFATE ION(Non-functional Binders)
- 17 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Da Fonseca, I. et al., Contributions of Unique Active Site Residues of Eukaryotic UDP-Galactopyranose Mutases to Substrate Recognition and Active Site Dynamics. Biochemistry (2014)
- Release Date
- 2014-12-03
- Peptides
- UDP-galactopyranose mutase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D